KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer

Waters, Andrew M., Der, Channing J.·2018·Cold Spring Harbor Perspectives in Medicine
DOI 10.1101/cshperspect.a031435

Cited by (882)

Items 501–600 of 882

  1. A novel refined pyroptosis and inflammasome-related genes signature for predicting prognosis and immune microenvironment in pancreatic ductal adenocarcinoma
    Jieliang Zuo, Chenhe Yi, Zhenmei Chen, Bo Zhou, Tingsong Yang, Jing Lin · 2022 · Scientific Reports
  2. An albumin‑binding domain and targeting peptide‑based recombinant protein and its enediyne‑integrated analogue exhibit directional delivery and potent inhibitory activity on pancreatic cancer with K‑ras mutation
    Weijin Sheng, Geng Jin, Liang Li, Yue Shang, Min Jiang, Yong‐Su Zhen · 2020 · Oncology Reports
  3. The type of KRAS mutation drives PI3Kα/γ signalling dependency: Implication for the choice of targeted therapy in pancreatic adenocarcinoma patients
    Coralie Cayron, Julie Guillermet‐Guibert · 2020 · Clinics and Research in Hepatology and Gastroenterology
  4. Screening of important metabolites and KRAS genotypes in colon cancer using secondary ion mass spectrometry
    Kookrae Cho, Eun‐Sook Choi, Sungyoung Lee, Jung‐Hee Kim, Dae Won Moon, Jong‐Wuk Son, Eunjoo Kim · 2020 · Bioengineering & Translational Medicine
  5. Pancreatic cancer driver mutations are targetable through distant alternative RNA splicing dependencies
    Ryan R. Kawalerski, Steven D. Leach, Luisa F. Escobar‐Hoyos · 2021 · Oncotarget
  6. Ras-dependent activation of BMAL2 regulates hypoxic metabolism in pancreatic cancer
    Alvaro Curiel-Garcia, Sam R. Holmstrom, Cristina Castillo, Carmine F. Palermo, Stephen A. Sastra, Anthony C. Andren, Lorenzo Tomassoni, Li Zhang, Tessa Y. S. Le Large, Irina R. Sagalovskiy et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  7. A Perspective on Covalent Inhibitors: Research and Development Trends of Warheads and Targets
    Haitao Chen, Robert E. Bird, Da-Sheng Wang, Leilani M. Lotti Diaz, Kavita A. Iyer, Gary R. Gustafson, Junko Kato-Weinstein, Qiongqiong Angela Zhou · 2023 · ChemRxiv
  8. Oncogenic KRAS Promotes Ferroptosis in Pancreatic Cancer Through Regulation of the Fosl1-Tfrc Axis
    Huijia Zhao, Qi Huang, Yingao Liu, Wenming Wu · 2024 · Pancreas
  9. DNA Origami‐Cyanine Nanocomplex for Precision Imaging of KRAS‐Mutant Pancreatic Cancer Cells
    Hye‐ran Moon, Yancheng Du, Sae Rome Choi, Seongmin Seo, Cih Cheng, Bennett D. Elzey, Jong Hyun Choi, Bumsoo Han · 2025 · Advanced Science
  10. Advances in biomarkers of resistance to KRAS mutation-targeted inhibitors
    Lihao Wang, Dandan Wei, Shanshan Li, Shiqing Jiang · 2025 · Discover Oncology
  11. CRISPR-Cas9 Screening Identifies Resistance Mechanisms to KRAS Inhibition in Pancreatic Cancer
    Szu-Aun Lim, Haley Todd, Grace Goodhart, Wen-Hsuan Chang, Amber M. Amparo, Rachel Bridgens, Julien Dilly, Se Jun Park, Robert M. Beal, Sara M. Shehadeh et al. · 2025 · Cancer Research
  12. Leveraging space innovations for cancer breakthroughs on Earth
    Hossein Akbarialiabad, Parnian Kord Jamshidi, Zahra Aminzade, Narges Azizi, Seyed Reza Taha, Najmeh Sadeghian, Lydia Johnson Kolaparambil Varghese, Mohsen Farjoud Kouhanjani, Nafise Niknam, Dora Babocs et al. · 2025 · Trends in cancer
  13. Prevention of Akt phosphorylation is a key to targeting cancer stem-like cells by mTOR inhibition
    Shyuichiro Matsubara, Koichiro Tsukasa, Taisaku Kuwahata, Sonshin Takao · 2020 · Human Cell
  14. Analysis of KRAS Mutation Subtype in Tissue DNA and Cell-Free DNA Using Droplet Digital PCR and the Function of Cell-Free DNA as a Recurrence Predictive Marker in Pancreatic Cancer
    Eunsung Jun, Bonhan Koo, Eo Jin Kim, Dae Wook Hwang, Jae Hoon Lee, Ki Byung Song, Woohyung Lee, Yejong Park, Sarang Hong, Yong Moon Shin et al. · 2021 · Biomedicines
  15. Senescence-Associated miRNAs and Their Role in Pancreatic Cancer
    Alexey Popov, Václav Mandys · 2022 · Pathology & Oncology Research
  16. Identification and Validation of a DNA Damage Repair‐Related Signature for Diffuse Large B‐Cell Lymphoma
    Li Yang, Xiyang Liu, Yu Chang, Bingjie Fan, Chenxing Shangguan, Huan Chen, Lei Zhang · 2022 · BioMed Research International
  17. Antiproliferative Activity of Krukovine by Regulating Transmembrane Protein 139 (TMEM139) in Oxaliplatin-Resistant Pancreatic Cancer Cells
    J.H. Lee, Sang Hyub Lee, Sang Kook Lee, Jin Ho Choi, Seohyun Lim, Min-Song Kim, Kyung-Min Lee, Min Woo Lee, Ja‐Lok Ku, Dae-Hyun Kim et al. · 2023 · Cancers
  18. Regulation of immune cell metabolism by cancer cell oncogenic mutations
    Alaa Madi, Guoliang Cui · 2020 · International Journal of Cancer
  19. Bitter melon juice intake with gemcitabine intervention circumvents resistance to gemcitabine in pancreatic patient‐derived xenograft tumors
    Deepanshi Dhar, Komal Raina, Dileep Kumar, Michael F. Wempe, Stacey M. Bagby, Todd M. Pitts, David J. Orlicky, Chapla Agarwal, Wells A. Messersmith, Rajesh Agarwal · 2020 · Molecular Carcinogenesis
  20. Autophagy in pancreatic cancer
    Congting Guo, Ying Zhao · 2021 · Journal of Molecular Cell Biology
  21. Combinatorial Treatment of Tinzaparin and Chemotherapy can Induce a Significant Antitumor Effectin Pancreatic Cancer
    Panagiotis Sarantis, Alexandros Bokas, Adriana Papadimitropoulou, Evangelos Koustas, Stamatios E Theocharis, Pavlos Papakotoulas, Dimitriοs Schizas, Alexandros Papalampros, Evangelos S. Felekouras, Athanasios G. Papavassiliou et al. · 2021 · Research Square
  22. Epichaperomes as a Gateway to Understanding, Diagnosing, and Treating Disease Through Rebalancing Protein–Protein Interaction Networks
    Chander Singh Digwal, Sahil Sharma, Anand Ramaian Santhaseela, Stephen D. Ginsberg, Gabriela Chiosis · 2022 · Wiley eBooks
  23. The crucial prognostic signaling pathways of pancreatic ductal adenocarcinoma were identified by single-cell and bulk RNA sequencing data
    Wenwen Wang, Guo Chen, Wenli Zhang, Xihua Zhang, Manli Huang, Chen Li, Ling Wang, Zi-Fan Lu, Jielai Xia · 2024 · Human Genetics
  24. Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma
    Mahmoud Yousef, Mark W. Hurd, Abdelrahman M.G. Yousef, Ethan Bernard Ludmir, Ashwathy Balachandran Pillai, Jennifer Peterson, Eugene Jon Koay, Sali Albarouki, Ching-Wei David Tzeng, Rebecca Anne Snyder et al. · 2024 · The Oncologist
  25. Sequence-defined phosphoestamers for selective inhibition of the KRAS G12D /RAF1 interaction
    Bini Claringbold, Steven Vance, Alexandra R. Paul, James Williamson, Michelle Dawn Garrett, Christopher J. Serpell · 2024 · Chemical Science
  26. Identification and validation of a novel autoantibody biomarker panel for differential diagnosis of pancreatic ductal adenocarcinoma
    Metoboroghene Oluwaseyi Mowoe, Hisham Allam, Joshua Nqada, Marc M. Bernon, Karan Gandhi, Sean Burmeister, Urda K. Kotze, Miriam Kahn, Christo Kloppers, Suba Dharshanan et al. · 2025 · Frontiers in Immunology
  27. Unraveling novel mechanisms of ATP-Binding cassette (ABC) transporter in insulin Resistance-induced amyloidogenesis
    AKHIL KUMAR SHARMA, Ashi Mannan, Thakur Gurjeet Singh · 2025 · Metabolic Brain Disease
  28. SIMPLE: A One-Pot RPA-Cas12b Method for Single Nucleotide Variations Identification with an Expanded Scope and Clinical Applications
    Kaiming Guo, Yongkang Lai, Yiru Han, Linlin Bai, Ting Wang, Shengzhou Wang, Ziqin Zhang, Dianwei Liu, Yanju Chen, Jiulong Zhao et al. · 2025 · Phenomics
  29. PTEN Oxidation Promotes Constitutive PI3K Signaling and Inducible Macropinocytosis in Pancreatic Cancer
    Rachel A. Burge, Lucas Bialousow, Amanda J. Linke, Hannah S. Coalson, Sara J. Adair, Kamala P. Sundararaj, Merissa Smith, Cameron Bumbleburg, Todd W. Bauer, David F. Kashatus et al. · 2025 · Cancer Research
  30. Amino acid transporter SLC7A11 functions in ferroptosis regulation and immune microenvironment in osteosarcoma
    Xueru Jia, Yangyang Shi, Jianrong Su, Yibo Zhou, Wei Li, Yajun Li, Baoshan Di, Fangyu An, Chunlu Yan · 2025 · International Immunopharmacology
  31. Broad-Spectrum RAS Inhibition in Pancreatic Ductal Adenocarcinoma: Mechanistic Advances and Therapeutic Promise
    Fawaz E. Alanazi, Yasser M. Alatawi, Abdullah Alattar, Reem Alshaman, Ahmed A. Kotb, ‏Helal F. Hetta · 2025 · Pharmaceuticals
  32. An overview of KRAS G12D inhibitors: Expanding the therapeutic frontier of KRAS in targeting KRAS G12D using diverse therapeutic modalities
    Varun Kumar, Abhinandan K. Danodia, Pradeep S. Jadhavar, Subhendu K. Mohanty, Swapan Samanta · 2026 · European Journal of Medicinal Chemistry
  33. Moving Towards Dawn: KRas Signaling and Treatment in Pancreatic Ductal Adenocarcinoma
    Sankha Bhattacharya, Tarun Rajpurohit · 2022 · Current Molecular Pharmacology
  34. PAK4 inhibition significantly potentiates Gemcitabine activity in PDAC cells via inhibition of Wnt/β-catenin, p-ERK/MAPK and p-AKT/PI3K pathways
    Charudatt Samant, Ramesh R. Kale, Anand M. Bokare, Mahip Verma, Karkala Sreedhara Ranganath Pai, Mandar Bhonde · 2023 · Biochemistry and Biophysics Reports
  35. Advancements and perspectives of RBX2 as a molecular hallmark in cancer
    Yiran Tao, Lirui Dai, Wulong Liang, Xiang Li, Yuan Lyu, Junqi Li, Zian Li, Zimin Shi, Xianyin Liang, Shaolong Zhou et al. · 2023 · Gene
  36. Towards Targeting Endothelial Rap1B to Overcome Vascular Immunosuppression in Cancer
    Behshid Ghadrdoost Nakhchi, Ramoji Kosuru, Magdalena Chrzanowska‐Wodnicka · 2024 · International Journal of Molecular Sciences
  37. The road to overcome pancreatic cancer: Where are we?
    Alexandru Tirpe, Cristian Streianu, Ekaterina Isachesku, Ioan Şimon, Ioana Berindan‐Neagoe · 2024 · Heliyon
  38. Macropinocytosis-targeted peptide-docetaxel conjugate for bystander pancreatic cancer treatment
    Young Seok Cho, Hanhee Cho, Ha Rin Kim, Seong Jin Park, Joo Hye Yeo, Yoon Gun Ko, Jinu Lee, Sang Yoon Kim, Kwangmeyung Kim, Youngro Byun · 2024 · Journal of Controlled Release
  39. Ras Family of Small GTPases in CRC: New Perspectives for Overcoming Drug Resistance
    Anxo Río-Vilariño, Laura del Puerto‐Nevado, Jesús García‐Foncillas, Arancha Cebrián · 2021 · Cancers
  40. Pancreatic Cancers: A Review of Studies from Pakistan and Comparison with Global Trends
    Saleema Mehboob Ali, Yumna Adnan, Syed Muhammad Adnan Ali · 2021 · Pakistan Journal of Public Health
  41. Genetic landscape of pancreatic adenocarcinoma patients: a pilot study from Pakistan
    Saleema Mehboob Ali, Yumna Adnan, Zubair Ahmad, Hasnain Ahmed Farooqui, Tabish Umer Chawla, Syed Muhammad Adnan Ali · 2021 · Molecular Biology Reports
  42. KRAS mutation allele frequency threshold alters prognosis in right‐sided resected pancreatic cancer
    David O. Nauheim, David Moskal, Bryan Renslo, Matthew Chadwick, Wei Jiang, Charles J. Yeo, Avinoam Nevler, Wilbur Bo Bowne, Harish Lavu · 2022 · Journal of Surgical Oncology
  43. Loss of Heterozygosity for KrasG12D Promotes Malignant Phenotype of Pancreatic Ductal Adenocarcinoma by Activating HIF-2α-c-Myc-Regulated Glutamine Metabolism
    Yu Ma, Sunkai Ling, Yuan Li, Mingyue Hu, Bo Kong, Peilin Huang, Hui Liu · 2022 · International Journal of Molecular Sciences
  44. Acid Adaptation Promotes TRPC1 Plasma Membrane Localization Leading to Pancreatic Ductal Adenocarcinoma Cell Proliferation and Migration through Ca2+ Entry and Interaction with PI3K/CaM
    Julie Schnipper, Sana Kouba, Frédéric Hague, Alban Girault, Marie‐Sophie Telliez, Stéphanie Guénin, Ahmed Ahidouch, Stine F. Pedersen, Halima Ouadid‐Ahidouch · 2022 · Cancers
  45. Systems biology and OMIC data integration to understand gastrointestinal cancers
    Iasmin Moreira Costa Bispo, Henry Paul Granger-Neto, Palloma Porto Almeida, Patrí­cia Belini Nishiyama, Leandro Martins de Freitas · 2022 · World Journal of Clinical Oncology
  46. KRAS Pathway-based Therapeutic Approaches in Pancreatic Cancer
    Abdullah Althaiban, Anita Thyagarajan‐Sahu, Ravi P. Sahu · 2022 · Mini-Reviews in Medicinal Chemistry
  47. Are Aspects of Integrative Concepts Helpful to Improve Pancreatic Cancer Therapy?
    Shiao Li Oei, Friedemann Schad · 2023 · Cancers
  48. Mychonastes sp. 246 Suppresses Human Pancreatic Cancer Cell Growth via IGFBP3-PI3K-mTOR Signaling
    Hyun‐Jin Jang, Soon Lee, Eunmi Hong, Kyung June Yim, Yong‐Soo Choi, Ji Young Jung, Z‐Hun Kim · 2022 · Journal of Microbiology and Biotechnology
  49. Albumin-conjugated drug is irresistible by single gene mutation of endocytic system: Verification by genome-wide CRISPR-Cas9 loss-of-function screens
    Yuan Fang, Mengnan Sun, Huiqin Liu, Feng Qian · 2020 · Journal of Controlled Release
  50. Perioperative cell-free mutant KRAS dynamics in patients with pancreatic cancer
    Julian Hipp, Saskia Hussung, Sylvia Timme‐Bronsert, Melanie Boerries, Esther A. Biesel, Stefan Fichtner‐Feigl, Ralph Fritsch, Uwe A. Wittel · 2021 · British journal of surgery
  51. Characterization of the tumor immune-microenvironment of adenocarcinoma of lung with a metastatic lesion in the pancreas treated successfully with first-line, single-agent pembrolizumab
    David L. Saltman, Tyler J. Nielsen, Davide Salina, David Richard Hout, Frank B. McMahon, Boris Valev, Michael Huk, Pranil Chandra, Jeremy Spille, Robert S. Seitz et al. · 2021 · Therapeutic Advances in Medical Oncology
  52. SuperDendrix algorithm integrates genetic dependencies and genomic alterations across pathways and cancer types
    Tae Yoon Park, Mark D.M. Leiserson, Gunnar W. Klau, Benjamin J. Raphael · 2022 · Cell Genomics
  53. Genome-Wide Characterization of Fennel (Anethum foeniculum) MiRNome and Identification of its Potential Targets in Homo sapiens and Arabidopsis thaliana: An Inter and Intra-species Computational Scrutiny
    Tithi S. Trivedi, Aafrinbanu M. Shaikh, Archana Mankad, Rakesh Rawal, Saumya Patel · 2023 · Biochemical Genetics
  54. Kinome state is predictive of cell viability in pancreatic cancer tumor and stroma cell lines
    Matthew E. Berginski, Madison R. Jenner, Chinmaya U. Joisa, Silvia G. Hererra, Brian T. Golitz, Matthew B. Lipner, John R Leary, Naim U. Rashid, Gary L. Johnson, Jen Jen Yeh et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  55. Anticipating resistance to KRAS inhibition: a novel role for USP21 in macropinocytosis regulation
    Howard C. Crawford · 2021 · Genes & Development
  56. Anti-proteolytic regulation of KRAS by USP9X/NDRG3 in KRAS-driven cancer development
    Han Koo, K. Park, H. Sohn, Min-Ho Kang, Dong Joon Kim, Zee-Yong Park, Sehoon Park, Sang-Hyun Min, Seong-Hwan Park, Yeon-Mi You et al. · 2025 · Nature Communications
  57. Alteration in Levels of Specific miRNAs and Their Potential Protein Targets between Human Pancreatic Cancer Samples, Adjacent Normal Tissue, and Xenografts Derived from These Tumors
    Fiona O’Neill, Taylor J. Allen-Coyle, Sandra Roche, Justine Meiller, Neil T. Conlon, Niall Swan, Robert M. Straubinger, Justin Geoghegan, Ninfa L. Straubinger, Kevin C. Conlon et al. · 2023 · Life
  58. A novel natural killer cell-related signatures to predict prognosis and chemotherapy response of pancreatic cancer patients
    Yongting Lan, Jia Qing, Min Hua Feng, Peiqing Zhao, Min Sheng Zhu · 2023 · Frontiers in Genetics
  59. The role of diagnostic, prognostic, and predictive biomarkers in the management of early pancreatic cancer
    Sarah Maloney, Stephen John Clarke, Sumit Sahni, Amanda L. Hudson, Emily K. Colvin, Anubhav Mittal, Jaswinder Singh Samra, Nick Pavlakis · 2023 · Journal of Cancer Research and Clinical Oncology
  60. Novel therapeutic strategies in pancreatic cancer: moving beyond cytotoxic chemotherapy
    Barbara Geerinckx, Laure-Anne Marie Nicole Teuwen, Tiffany Foo, Timon Vandamme, Annabel Smith, Marc Peeters, Timothy Jay Price · 2023 · Expert Review of Anticancer Therapy
  61. Systematic analysis of proteome turnover in an organoid model of pancreatic cancer by dSILO
    Alison B. Ross, Darvesh Gorhe, Jenny Kim Kim, Stefanie J. Hodapp, Lela DeVine, Karina M. Chan, Iok In Christine Chio, Marko Jovanović, Marina Ayres Pereira · 2024 · Cell Reports Methods
  62. MEK inhibitors and DA ‐Raf, a dominant‐negative antagonist of the Ras– ERK pathway, prevent the migration and invasion of KRAS ‐mutant cancer cells
    Aoi Matsuda, Ryuichi Masuzawa, Kazuya Takahashi, Kazunori Takano, Takeshi Endo · 2024 · Cytoskeleton
  63. Natural Product Graveoline Modulates Kirsten Rat Sarcoma Viral Oncogene Homologue (KRAS) Membrane Association: Insights from Advanced Spectroscopic Studies
    Gabriel Cornilescu, Lakshman K. Bindu, Louise M. Sternicki, Fa-An Chao, William Gillette, Nicole D. Fer, John Colombus, Jean Castillo, Pedro Andrade Bonilla, Que N. Van et al. · 2024 · ACS Pharmacology & Translational Science
  64. Mutational profiling of 103 unresectable pancreatic ductal adenocarcinomas using EUS-guided fine-needle biopsy
    Julie Buchberg, Karin de Stricker, Per Pfeiffer, Michael Bau Mortensen, Sönke Detlefsen · 2024 · Endoscopic Ultrasound
  65. Modulation of PRC1 Promotes Anticancer Effects in Pancreatic Cancer
    Hajin Lee, An-Na Bae, Huiseong Yang, Jae‐Ho Lee, Jong Ho Park · 2024 · Cancers
  66. TRIP13 protects pancreatic cancer cells against intrinsic and therapy-induced DNA replication stress
    Jay Ramanlal Anand, Gaith N. Droby, Sayali Joseph, Urvi Patel, Xingyuan Zhang, Jeffrey A. Klomp, Channing J. Der, Jeremy E. Purvis, Samuel C Wolff, Jessica L. Bowser et al. · 2025 · NAR Cancer
  67. Synchronous Ileal Metastasis from Pancreatic Ductal Adenocarcinoma: Case Report and Narrative Review with Practical Diagnostic and Management Points
    Tiberiu Ștefăniță Țenea Cojan, Valeriu Şurlin, Stelian Ştefăniţă Mogoantă, Nicolae-Dragoș Mărgăritescu, Daniel-Cosmin Caragea, Ioana-Alexia Țenea Cojan, Valentina Căluianu, Marius Cristian Marinaş, Gabriel Florin Răzvan Mogoș, Liviu Vasile et al. · 2025 · Life
  68. Isolated Ovarian Metastasis from Pancreatic Cancer Mimicking Primary Ovarian Neoplasia: Role of Molecular Analysis in Determining Diagnosis
    Catherine M. Tucker, Cheryl L. Godcharles, Wei Jiang, Charles J. Yeo, Norman G. Rosenblum, Ethan J. Halpern, William E. Luginbuhl, Anthony J. Prestipino · 2021 · Journal of Pancreatic Cancer
  69. A novel genomic instability-derived lncRNA signature to predict prognosis and immune characteristics of pancreatic ductal adenocarcinoma
    Huijie Yang, Weiwen Zhang, Jin Ding, Jingyi Hu, Yi Eve Sun, Weijun Peng, Yi Chu, Lingxiang Xie, Zubing Mei, Zhuo Shao et al. · 2022 · Frontiers in Immunology
  70. Metabolic signatures in pancreatic ductal adenocarcinoma: diagnostic and therapeutic implications
    Ruining Gong, Yonglu Hu, Qian Yu, Lin Fang, He Ren · 2023 · Journal of Pancreatology
  71. A Comparative Study of Patient-Derived Tumor Models of Pancreatic Ductal Adenocarcinoma Involving Orthotopic Implantation
    Kazuyoshi Yanagihara, Yuki Iino, Hiroshi Yokozaki, Takanori Kubo, Tatsuya Oda, Takashi Kubo, Masayuki Komatsu, Hiroki Sasaki, Hitoshi Ichikawa, Takeshi Kuwata et al. · 2022 · Pathobiology
  72. Circulating Nucleic Acids as Novel Biomarkers for Pancreatic Ductal Adenocarcinoma
    Ryan McGowan, Áine Sally, Anthony McCabe, Brian Michael Moran, Karen Finn · 2022 · Cancers
  73. Impact of Oncogenic Targets Controlled by Tumor-SuppressivemiR-30a-5pin Pancreatic Ductal Adenocarcinoma
    Pramod Nepal, Yuto Hozaka, Takako Tanaka, Masumi Wada, Shunichi Asai, Chikashi Minemura, Tetsuya Idichi, Takaaki Arigami, Hiroshi Kurahara, Naohiko Seki et al. · 2021 · Anticancer Research
  74. Clonal Heterogeneity in Human Pancreatic Ductal Adenocarcinoma and Its Impact on Tumor Progression
    Despoina Kalfakakou, Daniel C. Cameron, Emily A. Kawaler, Motoyuki Tsuda, Lidong Wang, Xiaohong Jing, Cristina H Hajdu, Dylan L. Tamayo, Yoona Shim, Amanda Ackermann et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  75. Structure–activity relationships of KRAS-G12D inhibitors for pancreatic cancer
    Chetna Suyal, Selanere S. Mangala, Anoop Kishore, Suvarna G. Kini · 2025 · Drug Discovery Today
  76. Harnessing the gut microbiome to modulate ferroptosis: a metabolic strategy for the treatment of digestive tract cancers
    Jiexia Wen, Huagang Liang, Min Zhao, Bin Xuan, Xiangcai Meng, Yang Liu, Liwei Wang, Li He, Tao Zhou, Yang Tao et al. · 2025 · Frontiers in Immunology
  77. Discovery of a Novel Dual-Targeting KRAS G12D /HDAC Peptide Inhibitor for the Treatment of Pancreatic Cancer
    Qiaoxuan Zhang, Yifei Geng, Haitao Chen, Jiaping Ni, Lixia Guan, Dongqing Zhai, Yuting Wang, Shengtao Xu, Miaomiao Niu, Lufeng Zheng et al. · 2026 · Journal of Medicinal Chemistry
  78. Deciphering RTK-RAS and MAPK Pathway Dependencies in Gemcitabine-Treated Pancreatic Ductal Adenocarcinoma Through Conversational Artificial Intelligence
    Fernando C. Diaz, Brigette Waldrup, Francisco Carranza, Sophia Manjarrez, Enrique I. Velazquez-Villarreal · 2026 · International Journal of Molecular Sciences
  79. RBPJ Deficiency Sensitizes Pancreatic Acinar Cells to KRAS-Mediated Pancreatic Intraepithelial Neoplasia Initiation
    Leiling Pan, Medhanie Assmelash Mulaw, Johann Gout, Min Guo, Hina Zarrin, Peggy Schwarz, Bernd Baumann, Thomas Theodor Werner Seufferlein, Martin Wagner, Franz Oswald · 2023 · Cellular and Molecular Gastroenterology and Hepatology
  80. The role of HSP40 in cancer: Recent advances.
    Bi-Xi Zhong, Fu‐Ming Shen, Ji‐Kuai Chen · 2024 · PubMed
  81. KRAS degradation averts PDAC chemoresistance
    Laura Leonhardt, Matthias Hebrok · 2024 · Nature Cancer
  82. KRAS Inhibition Activates an Actionable CD24 “Do Not Eat Me” Signal in Pancreatic Cancer
    Yongkun Wei, Minghui Liu, Er-Yen Yen, Jun Yao, Zhenzhen Xun, Phuoc Thi-My Nguyen, Xiaofei Wang, Zecheng Yang, Abdelrahman M.G. Yousef, Dean N. Pan et al. · 2025 · Cancer Research
  83. TRYBECA-1: A Randomized Phase III Study of Eryaspase Combined With Chemotherapy Versus Chemotherapy as Second-Line Treatment in Patients With Advanced Pancreatic Adenocarcinoma
    Pascal R. Hammel, Jean‐Philippe Metges, Teresa Mercade Macarulla, Rocio García‐Carbonero, Olivier Bouché, Fabienne Portales, Roberto Pazo-Cid, Laurent Mineur, Antonio Cubillo Gracián, Isabelle Trouilloud et al. · 2025 · Journal of Clinical Oncology
  84. Liquid Biopsy as a Prognostic and Theranostic Tool for the Management of Pancreatic Ductal Adenocarcinoma
    Daniel Osei‐Bordom, Gagandeep Singh Sachdeva, Niki Christou · 2022 · Frontiers in Medicine
  85. Combined HASPIN and mTOR inhibition is synergistic against KRAS-driven carcinomas
    Chenyue Xu, Qiongmei Gao, ZhengMing Wu, Weijuan Lou, Xiaoyan Li, Nianhong Wang, Nianhong Wang, Qingquan Li · 2022 · Translational Oncology
  86. Comparison of biological behavior of lacrimal gland adenoid cystic carcinoma with high-grade transformation cells
    Chuan-Li Zhang, Xun Liu, Meixia Jiang, Tingting Lin, Yanjin He · 2023 · International Journal of Ophthalmology
  87. A Probabilistic Approach to Estimate the Temporal Order of Pathway Mutations Accounting for Intra-Tumor Heterogeneity
    Menghan Wang, Yanqi Xie, Jinpeng Liu, Austin Li, Li Chen, Arnold J. Stromberg, Susanne M. Arnold, Chunming Liu, Chi Wang · 2024 · Cancers
  88. Novel druggable space in human KRAS G13D discovered using structural bioinformatics and a P-loop targeting monoclonal antibody
    Oscar Jungholm, Carolina L. Trkulja, Martin Moche, Sreesha P. Srinivasa, Maria-Nefeli Christakopoulou, Max Davidson, Anna Reymer, Kent E. Jardemark, Rafaela L Fogaça, Anaswara Ashok et al. · 2024 · Scientific Reports
  89. Systemic Therapy for Metastatic Pancreatic Cancer—Current Landscape and Future Directions
    Daniel Netto, Melissa Frizziero, Victoria Foy, Mairead Geraldine McNamara, Alison Catherine Backen, Richard A Hubner · 2024 · Current Oncology
  90. Integrating CRISPR Technology with Key Genetic Markers in Pancreatic Cancer: A New Frontier in Targeted Therapies
    Dimitrios Stefanoudakis · 2025 · SynBio
  91. Advancing targeted therapies in pancreatic cancer: Leveraging molecular abberrations for therapeutic success
    Tanvi Gupta, Mohd Murtaza · 2025 · Progress in Biophysics and Molecular Biology
  92. Online informatics resources to facilitate cancer target and chemical probe discovery
    Xuan Yang, Haian Fu, Andrei A. Ivanov · 2020 · RSC Medicinal Chemistry
  93. In Silico Epitope Prediction Analyses Highlight the Potential for Distracting Antigen Immunodominance with Allogeneic Cancer Vaccines
    C. Alston James, Peter Ronning, Darren R. Cullinan, Kelsy C. Cotto, Erica Kay Barnell, Katie Marie Campbell, Zachary L. Skidmore, Dominic E. Sanford, Simon Peter Goedegebuure, William E. Gillanders et al. · 2021 · Cancer Research Communications
  94. Use of the Biocartis Idylla™ Platform for the Detection of Epidermal Growth Factor Receptor, BRAF and KRAS Proto-Oncogene Mutations in Liquid-Based Cytology Specimens from Patients with Non-Small Cell Lung Carcinoma and Pancreatic Adenocarcinoma
    Leonie Wheeldon, Mary Jones, Ben Probyn, Dushyant Shetty, James Garvican · 2022 · Journal of Molecular Pathology
  95. Knockdown of 15-bp Deletion-Type v-raf Murine Sarcoma Viral Oncogene Homolog B1 mRNA in Pancreatic Ductal Adenocarcinoma Cells Repressed Cell Growth In Vitro and Tumor Volume In Vivo
    Jiaxuan Song, Yoshiaki Kobayashi, Yoshimasa Asano, Atsushi Sato, Hiroaki Taniguchi, Kumiko Ui‐Tei · 2022 · Cancers
  96. Mechanistic and functional extrapolation of SET and MYND domain-containing protein 2 to pancreatic cancer
    Eid S. Alshammari, Yingxue Zhang, Zhe Yang · 2022 · World Journal of Gastroenterology
  97. Modeling Obesity-Driven Pancreatic Carcinogenesis—A Review of Current In Vivo and In Vitro Models of Obesity and Pancreatic Carcinogenesis
    Sally Kfoury, Patrick Michl, Laura Roth · 2022 · Cells
  98. NFL-TBS.40-63 Peptide Gold Complex Nanovector: A Novel Therapeutic Approach to Increase Anticancer Activity by Breakdown of Microtubules in Pancreatic Adenocarcinoma (PDAC)
    Qiqian Liu, Hui Liu, Audrey Griveau, Xiaowu Li, Joël Eyer, Célia Arib, Jolanda Spadavecchia · 2022 · ACS Pharmacology & Translational Science
  99. Integrated Analysis of the Role of Enolase 2 in Clear Cell Renal Cell Carcinoma
    Jiaren Pan, Yanyan Jin, Xiaoming Xu, Wei Wei, Huafeng Pan · 2022 · Disease Markers
  100. The Mutation Portraits of Oncogenes and Tumor Supressor Genes in Predicting the Overall Survival in Pancreatic Cancer: A Bayesian Network Meta-Analysis
    Citra Aryanti, Julianus Aboyaman Uwuratuw, Ibrahim Labeda, Warsinggih Raharjo, Ronald Erasio Lusikooy, Murny Abdul Rauf, Andi Mappincara, Samuel Sampetoding, Muhammad Ihwan Kusuma, Erwin Syarifuddin · 2023 · Asian Pacific Journal of Cancer Prevention